15.17
Pulse Biosciences Inc Azioni (PLSE) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
-
|
- | - | - | - |
Research and Development |
17.21%
12.09
|
10.31 | 10.66 | 7.703 | 7.23 |
Costs And Expenses |
12.36%
20.27
|
18.04 | 20.26 | 13.65 | 11.73 |
Operating Income/Loss |
12.36%
-20.27
|
-18.04 | -20.26 | -13.65 | -11.73 |
Nonoperating Income/Loss |
11.37%
1.107
|
1.249 | 0.876 | 0.975 | 0.343 |
Income/Loss From Continuing Operations Before Tax |
14.13%
-19.17
|
-16.80 | -19.39 | -12.68 | -11.38 |
Income Tax Expense/Benefit |
-
|
- | - | - | - |
Income/Loss From Continuing Operations After Tax |
14.13%
-19.17
|
-16.80 | -19.39 | -12.68 | -11.38 |
|
14.13%
-19.17
|
-16.80 | -19.39 | -12.68 | -11.38 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.22%
67.28
|
67.13 | 1.229 | 61.07 | 57.18 |
Basic Earnings Per Share |
12.00%
-0.28
|
-0.25 | -0.32 | -0.21 | -0.20 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):